RecruitingNCT07085533
Natural History Study of Inherited Retinal Diseases
Studying Achromatopsia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Zhongmou Therapeutics
- Principal Investigator
- Yin ShenRenmin Hospital of Wuhan University
- Enrollment
- 200 enrolled
- Eligibility
- All sexes
- Timeline
- 2025 – 2027
Study locations (1)
- Renmin Hospital of Wuhan University, Wuhan, China
Collaborators
Wuhan University · Renmin Hospital of Wuhan University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07085533 on ClinicalTrials.govOther trials for Achromatopsia
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT02935517Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)Beacon Therapeutics
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT02599922Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial)Beacon Therapeutics
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT02610582Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked AchromatopsiaSTZ eyetrial